BioStrand Omics Analysis Blog:
Multi-Omics

The role of NGS in breast cancer diagnosis and treatment

Breast cancer is the most common cancer in women worldwide, accounting for 25% of all female...

The metadata challenge in biological research

One of the key highlights of the global response to COVID-19 has been the importance of ...

Learnings from the global response to the pandemic

Prior to 2020, the fastest vaccine development program had taken four years from viral sampling...

The future of precision medicine

The sequencing of the human genome heralded a potential revolution in healthcare. So much so...

Multidimensional scalability in multi-omics research

In 2018, the Joint Genome Institute (JGI) achieved a sequencing output of 200 trillion bases, a...

Subscribe to our blog

Multi-omics data in biomarker discovery

Current diagnostic alternatives for neurodegenerative diseases like Alzheimer’s, Parkinson’s,...

Build vs. Buy: 7 Pros and Cons to Consider

There are multiple challenges associated with an increasing amount of data of which a key...

Convenience, Scalability, and Integration, in Three Flavours of BioStrand R&R

Omics data related to the genome, proteome and transcriptome is the very lifeblood of Life...

Making all omics data computable

At the beginning of the last decade, the Harvard Business Review described data science as the ...

Finish Your PhD Faster with BioStrand R&R

It has been two decades since the publication of the much-heralded first draft of a composite...

Harnessing the power of sequence information to enable the next breakthroughs in biology

The availability of high-quality genomes, transcriptome and protein assemblies are crucial for...